Search Results for "Alnylam"
Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.
More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.
For more information about our FDA-approved therapies, please see the Full Prescribing Information:
Patisiran: Blood Brain Barrier
Standard response letter containing pre-clinical data on the tissue distribution of patisiran.
Standard response letter containing pre-clinical data on the tissue distribution of patisiran.
Patisiran: Hospitalization and Mortality
Standard response letter on hospitalization and mortality data from patisiran clinical trials.
Standard response letter on hospitalization and mortality data from patisiran clinical trials.
Zilebesiran: KARDIA-3 Study
Standard response letter on zilebesiran and the KARDIA-3 study, an ongoing phase 2 study evaluating the efficacy and safety of zilebesiran in patients with high CV risk and hypertension that is not adequately controlled with at least 2 standard-of-care antihypertensives.
Standard response letter on zilebesiran and the KARDIA-3 study, an ongoing phase 2 study evaluating the efficacy and safety of zilebesiran in patients with high CV risk and hypertension that is not adequately controlled with at least 2 standard-of-care antihypertensives.
Vutrisiran: Self-Administration
Standard response letter on vutrisiran and self-administration.
Standard response letter on vutrisiran and self-administration.
Patisiran: APOLLO Study Results
Standard response letter on patisiran and the APOLLO study, a phase 3 study evaluating the efficacy and safety of patisiran in patients with the polyneuropathy of hATTR.
Standard response letter on patisiran and the APOLLO study, a phase 3 study evaluating the efficacy and safety of patisiran in patients with the polyneuropathy of hATTR.
Vutrisiran: Echocardiographic Assessments in HELIOS-B
Standard response letter on vutrisiran and exploratory echocardiographic assessments of cardiac structure and function in HELIOS-B.
Standard response letter on vutrisiran and exploratory echocardiographic assessments of cardiac structure and function in HELIOS-B.
Vutrisiran: Pregnancy & Lactation
Standard response letter on vutrisiran and pregnancy & lactation. This letter contains information on preclinical toxicology studies and the HELIOS-A and HELIOS-B studies.
Standard response letter on vutrisiran and pregnancy & lactation. This letter contains information on preclinical toxicology studies and the HELIOS-A and HELIOS-B studies.
Vutrisiran: Vitamin A Levels
Standard response letter on vutrisiran and vitamin A levels, including information on supplementation.
Standard response letter on vutrisiran and vitamin A levels, including information on supplementation.
